Advanced search
Most relevant results are first | Show most recent results first | Show use by person

Results 201-220 of 962 for hpv

Written Answers — Vaccination Programme: Vaccination Programme (19 Feb 2009) See 1 other result from this answer

Mary Harney: All of the clinical advice available to me indicates that the national roll-out of a cervical screening programme should take precedence over the introduction of a HPV vaccination programme. The National Cervical Screening Programme, CervicalCheck, is being implemented at a full year cost of €35m. In relation to the cost of the HPV vaccine, it is a matter for the Health Service Executive,...

Written Answers — Department of Health: Vaccination Programme (12 Jul 2016)

Simon Harris: ...are based on the epidemiology of the disease in Ireland and international best practice in relation to immunisation. Each year in Ireland around 300 women are diagnosed with cervical cancer. The HPV vaccine protects against two high risk types of HPV (16 & 18) that cause 73% of all cervical cancers. Vaccinated women and girls will still be at risk from other high risk types of...

Public Accounts Committee: Implications of CervicalCheck Revelations (Resumed)
2016 Financial Statements of the State Claims Agency (Resumed)
2016 Financial Statements of the HSE (Resumed)
(17 May 2018)

Kate O'Connell: ...on dealing with telling patients. Feelings might have really come to the fore if we were putting patients at the centre of this, not data. Earlier, Dr. O'Keeffe referred to her role in the HPV vaccine programme. I refer to any elected Deputy in this House who, through their reckless and irresponsible contributions, has previously contributed to the downward trend in the uptake of the...

Seanad: Order of Business (Resumed) (15 May 2018)

Colm Burke: I want to raise an issue related to CervicalCheck and the human papillomavirus, or HPV, vaccine. It is unfortunate that some of the people who were to the forefront criticising the HPV vaccine programme are now to the forefront in criticising the errors in the CervicalCheck scheme. Interestingly, two of the individuals concerned appeared on a television programme recently, yet neither of...

Written Answers — Department of Health: Vaccination Programme (22 Mar 2016)

Leo Varadkar: ...a number of specialties including infectious diseases, paediatrics and public health. The committee's recommendations are informed by public health advice and international best practice. The HPV vaccine protects girls from developing cervical cancer when they are adults. It is available free of charge from the HSE for all girls in 1st year of secondary school. Each year in...

Written Answers — Department of Health: Cancer Incidence (11 Oct 2018)

Simon Harris: ... 2007 6 0.79 2008 1 0.13 2009 3 0.38 2010 3 0.39 2011 1 0.13 2012 1 0.13 2013 2 0.26 2014 5 0.65 2015 2 0.26 2016 2 0.26 While data is not available on the Human Papillomavirus (HPV) status of these cases, 99% of cervical cancers are caused by persistent infection of certain high risk HPV types. HPV immunisation is a very important part of our childhood...

Written Answers — Department of Health: Cancer Screening Programmes (11 Dec 2018)

Simon Harris: I propose to take Questions Nos. 328 and 329 together. I take it that the Deputy is referring to the on-going preparation for the move to HPV testing as the primary screening mechanism for CervicalCheck. As the Deputy will be aware, switching to HPV testing as the primary screening mechanism will require a reconfiguration of laboratory services. While it is likely that a tendering...

Written Answers — Vaccination Programme: Vaccination Programme (12 Apr 2011)

James Reilly: I understand the Deputy is referring to the HPV vaccination. I have asked the HSE to develop an implementation plan for a catch-up programme for HPV vaccination of girls in secondary school to commence in the new school year this autumn.

Written Answers — Department of Health: Vaccination Programme (20 Jun 2017) See 8 other results from this answer

Billy Kelleher: 1251. To ask the Minister for Health the timeframe for the extension of the national immunisation programme for HPV to boys in view of the fact that 39,000 men worldwide die of HPV related cancer each year; and if he will make a statement on the matter. [27596/17]

Joint Oireachtas Committee on Health: Cancer Screening Programmes: Discussion (23 May 2018) See 7 other results from this debate

Ms Marie Culliton: Once the HPV testing has been introduced, it will be possible to reduce the screening frequency from three years to five years by using HPV triage, so one will also change the programme.

CervicalCheck: Statements (9 May 2019) See 2 other results from this debate

Simon Harris: It is still my intention for the HPV test to be introduced by the end of the year. We have reached an agreement with MedLab whereby it already uses the HPV test with regard to its backlog, which is an important point.

Written Answers — Department of Health: Vaccination Programme (10 Feb 2021)

Aengus Ó Snodaigh: 912. To ask the Minister for Health the status of the provision of the HPV vaccine at the gay men's health service; if the HPV vaccine will be offered through the service in the future; and if he will make a statement on the matter. [7202/21]

Written Answers — Department of Health: Vaccination Programme (10 Mar 2021)

Emer Higgins: 810. To ask the Minister for Health if those who were absent from school on the day of the human papillomavirus, HPV, vaccine administration and the catch-up programme can still receive the HPV vaccine free of charge (details supplied). [12807/21]

Written Answers — Department of Health: Health Services (14 Dec 2021)

Colm Burke: 648. To ask the Minister for Health if he will provide details of the efficacy of the new cervical cancer test that detects HPV; the number of tests that have been HPV positive with no abnormal cell changes; and if he will make a statement on the matter. [61699/21]

Written Answers — Department of Health: Vaccination Programme (22 Jan 2019) See 1 other result from this answer

Simon Harris: ...the safety and quality of all medicines including vaccines that are licensed in Ireland. The HPRA and the European Medicines Agency (EMA) continually monitor adverse events to vaccination. HPV is one of the most closely studied and monitored medicinal products. All medicines, including vaccines are subject to on-going review and evaluation of all available data from a range of sources,...

Written Answers — Department of Health: Vaccination Programme (21 Apr 2015) See 1 other result from this answer

Leo Varadkar: ...this issue. The report from this Group is available on my Department's website (www.health.gov.ie). There are no plans to introduce a vaccine damage compensation scheme at this time. The HPV vaccine protects girls from developing cervical cancer when they are adults. It is available free of charge from the HSE for all girls in 1st year of secondary school. This is in accordance...

Select Committee on Health: Estimates for Public Services 2017
Vote 38 - Health (Revised)
(2 Mar 2017) See 1 other result from this debate

Simon Harris: ...of work that we have to do and his own interest in this issue. I will continue to work with the Chairman and the committee in this regard. I am pleased that the Chairman raised the issue of the HPV vaccine, which is something that we have discussed at the committee previously. The focus for 2017 is to counter misinformation on the safety of this vaccine and to increase the uptake rate...

Written Answers — Department of Health: Vaccination Programme (16 Jun 2015) See 1 other result from this answer

Thomas Pringle: 643. To ask the Minister for Health his plans to address the concerns of parents over the Human Papilloma Virus (HPV) vaccine Gardasil; the level of his Department's engagement in an information campaign for parents, schools and children undergoing HPV vaccination; and if he will make a statement on the matter. [23781/15]

Written Answers — Department of Health: Vaccination Programme (8 Feb 2018) See 1 other result from this answer

Alan Kelly: 87. To ask the Minister for Health when the HPV vaccine is to be extended to boys; when the report of the health technology assessment being carried out by HIQA in respect of the HPV vaccine for boys will be published; and if he will make a statement on the matter. [6096/18]

Written Answers — Department of Health: Vaccination Programme (27 Feb 2018) See 1 other result from this answer

Fiona O'Loughlin: 529. To ask the Minister for Health if the HPV vaccine is to be extended to boys; when the report of the health technology assessment being carried out by HIQA in respect of the HPV vaccine for boys will be published; and if he will make a statement on the matter. [10167/18]

   Advanced search
Most relevant results are first | Show most recent results first | Show use by person